Amelie V. Guitart
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
Journal: Nature cancer
Published: March 31, 2023
CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.
Journal: Stem cell reports
Published: June 02, 2021
α-Tocopherol Attenuates Oxidative Phosphorylation of CD34+ Cells, Enhances Their G0 Phase Fraction and Promotes Hematopoietic Stem and Primitive Progenitor Cell Maintenance.
Journal: Biomolecules
Published: February 23, 2021
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 07, 2020
JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells.
Journal: Blood advances
Published: June 17, 2020
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
Journal: International journal of molecular sciences
Published: June 21, 2019
Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL.
Journal: Haematologica
Published: September 12, 2018
Ca2+tapulting HSCs into action.
Journal: The Journal of experimental medicine
Published: July 14, 2018
Last Updated: 09/26/2026